Details of the Drug

General Information of Drug (ID: DMELYJ9)

Drug Name

INV-1120

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04443088) A Phase 1, Multi-Center, Safety, Dose Escalation, Pharmacokinetics of INV-1120 in Adult Patients Advanced Solid Tumors. U.S. National Institutes of Health.